Jamil S Syed
Overview
Explore the profile of Jamil S Syed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
203
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahman S, Lokeshwar S, Syed J, Javier-DesLoges J, Press B, Choksi A, et al.
Urol Oncol
. 2022 Dec;
41(2):107.e1-107.e8.
PMID: 36481253
Background: There is lack of consensus about the effectiveness of neoadjuvant platinum-based chemotherapy in patients with micropapillary variant urothelial carcinoma (MVUC) prior to radical cystectomy. We studied the association between...
2.
Syed J, Khan A, Van-Ryn M, Ludvigson A, Motamedinia P
Urology
. 2022 Mar;
165:134-138.
PMID: 35314184
Objective: To assess the use of intraoperative IV ketorolac (Toradol) on the peri-operative total morphine milligram equivalent (MME) requirements of patients undergoing ureteroscopy for nephrolithiasis. Methods: Patients undergoing ambulatory ureteroscopy...
3.
Lokeshwar S, Syed J, Segal D, Rahman S, Sprenkle P
Curr Oncol Rep
. 2022 Jan;
24(2):249-256.
PMID: 35080739
Purposeof Review: The use of genomic testing for prostate cancer continues to grow; however, utilization remains institutionally dependent. Herein, we review current tissue-based markers and comment on current use with...
4.
Ghabili K, Paulson N, Syed J, Nawaf C, Khajir G, Martin D, et al.
Case Rep Urol
. 2021 May;
2021:2687416.
PMID: 33936831
The utility of serial Decipher biopsy scores in a true active surveillance population is still unknown. In a man on active surveillance for low-risk prostate cancer, a doubling of the...
5.
Syed J, Honig S
Sex Med Rev
. 2021 Feb;
9(2):236-243.
PMID: 33608246
Introduction: Feminizing gender-affirming surgery (GAS) has been an increasingly used procedure in the United States and worldwide for transgender women with gender dysphoria. Studies on patient-reported quality of life outcomes...
6.
McGillivray P, Ueno D, Pooli A, Mendhiratta N, Syed J, Nguyen K, et al.
Eur Urol
. 2020 Sep;
79(1):107-111.
PMID: 32972793
Renal oncocytoma (RO) accounts for 5% of renal cancers and generally behaves as a benign tumor with favorable long-term prognosis. It is difficult to confidently distinguish between benign RO and...
7.
8.
Syed J, Brito J, Pooli A, Boutros P, Shuch B
Urol Oncol
. 2020 Mar;
38(10):742-754.
PMID: 32222350
Improvements in chemistry, molecular biology, genetics, and bioinformatics have allowed broad use of transcriptomic profiling. Understanding the population of ribonucleic acid (RNA) transcripts can provide important clinical information relevant to...
9.
Grinberg A, Sellinger J, Sprenkle P, Bandin A, Nawaf C, Syed J, et al.
Urology
. 2020 Jan;
137:26-32.
PMID: 31893532
Objective: To improve the tolerability of transrectal ultrasound guided prostate biopsy through use of diaphragmatic breathing. Methods: Forty-seven patients, aged 52-79 years, who were scheduled for a transrectal ultrasound guided...
10.
Suarez-Sarmiento Jr A, Nguyen K, Syed J, Nolte A, Ghabili K, Cheng M, et al.
Clin Genitourin Cancer
. 2019 Sep;
17(6):e1163-e1170.
PMID: 31519468
Background: Brain metastases (BM) are frequently observed in advanced renal-cell carcinoma (RCC). Historically these individuals have been excluded from clinical trials, but recently, with better local control, many can receive...